Willner & Heller LLC Has $268,000 Stock Position in Axon Enterprise, Inc $AXON

by · The Markets Daily

Willner & Heller LLC lowered its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 63.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 478 shares of the biotechnology company’s stock after selling 834 shares during the quarter. Willner & Heller LLC’s holdings in Axon Enterprise were worth $268,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Rockefeller Capital Management L.P. lifted its holdings in Axon Enterprise by 53.2% during the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after purchasing an additional 4,002 shares during the last quarter. Legal & General Group Plc grew its stake in Axon Enterprise by 1.3% during the fourth quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after buying an additional 5,419 shares during the last quarter. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $13,116,000. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Axon Enterprise during the first quarter worth approximately $15,067,000. Finally, Harel Insurance Investments & Financial Services Ltd. raised its stake in shares of Axon Enterprise by 40.7% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock valued at $6,406,000 after acquiring an additional 4,360 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

  • Positive Sentiment: Revenue increased 35.3% year over year to $904.4 million, exceeding analysts’ expectations of approximately $876 million. Annual recurring revenue rose 39% to $1.6 billion, while net revenue retention reached 126%. Axon Q2 2026 revenue release
  • Positive Sentiment: Growth was particularly strong in newer businesses: AI Era revenue nearly quadrupled from the prior year, Platform Solutions revenue increased 123% to $150 million, and Dedrone counter-drone revenue surpassed $100 million. Management also raised its full-year revenue-growth outlook to 32%-34% while maintaining its 25.5% adjusted EBITDA margin target. Axon AI and drone growth report
  • Neutral Sentiment: Non-GAAP earnings were $1.88 per share, roughly in line with or slightly above different analyst estimates, but down from $2.12 a year earlier. Reported net income was $29 million, compared with $155 million in non-GAAP net income, highlighting the impact of adjustments. Axon Q2 earnings metrics
  • Negative Sentiment: Quarterly gross margin declined as professional services represented a larger share of sales and the company invested to scale newer products. Higher inventory also raised concerns about working-capital efficiency. Reuters report on Axon margins
  • Negative Sentiment: The reaction reflects elevated expectations for AXON, which trades at a very high valuation. Investors may be concerned that rapid AI and hardware expansion will take time to translate into sustained earnings growth, particularly as the company’s net margin remains modest. Axon margin and inventory report

Insider Activity

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the completion of the transaction, the insider directly owned 52,813 shares in the company, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Patrick W. Smith sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $10,000,000.00. Following the transaction, the chief executive officer directly owned 3,060,997 shares in the company, valued at $1,530,498,500. This trade represents a 0.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 58,989 shares of company stock valued at $30,527,983. Corporate insiders own 4.20% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent analyst reports. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Needham & Company LLC lifted their price objective on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Monday, July 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Finally, Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $688.38.

View Our Latest Stock Analysis on Axon Enterprise

Axon Enterprise Trading Up 0.4%

AXON opened at $609.49 on Thursday. The firm’s fifty day moving average is $509.69 and its two-hundred day moving average is $474.71. The firm has a market cap of $49.12 billion, a PE ratio of 244.78, a price-to-earnings-growth ratio of 12.39 and a beta of 1.39. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.00. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the previous year, the business earned $2.12 EPS. The firm’s revenue was up 35.3% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).